{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:49:03Z","timestamp":1790174943756,"version":"4.1.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1093\/carcin\/bgr176","type":"journal-article","created":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T20:19:21Z","timestamp":1311970761000},"page":"1550-1558","source":"Crossref","is-referenced-by-count":20,"title":["Arsenic disulfide synergizes with the phosphoinositide 3-kinase inhibitor PI-103 to eradicate acute myeloid leukemia stem cells by inducing differentiation"],"prefix":"10.1093","volume":"32","author":[{"given":"Zhenya","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunrui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danmei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,7,29]]},"reference":[{"key":"key\n\t\t\t\t20170520220354_bib1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2010.04.001","article-title":"Arsenic trioxide\u2014an old drug rediscovered","volume":"24","author":"Emadi","year":"2010","journal-title":"Blood Rev."},{"key":"key\n\t\t\t\t20170520220354_bib2","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1182\/blood-2009-01-198911","article-title":"Differentiation therapy of leukemia: 3 decades of development","volume":"113","author":"Nowak","year":"2009","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170520220354_bib3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(77)91415-5","article-title":"15\/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia","volume":"1","author":"Rowley","year":"1977","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170520220354_bib4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/ncb1716","article-title":"RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation","volume":"10","author":"Tatham","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"key\n\t\t\t\t20170520220354_bib5","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/sj.leu.2403424","article-title":"A clinical and pharmacological study of arsenic trioxide in advanced multiple myeloma patients","volume":"18","author":"Rousselot","year":"2004","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20170520220354_bib6","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.bbmt.2008.09.019","article-title":"Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial","volume":"14","author":"Qazilbash","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"key":"key\n\t\t\t\t20170520220354_bib7","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1158\/1078-0432.CCR-06-1812","article-title":"A phase I\/II study of arsenic trioxide\/bortezomib\/ascorbic acid combination therapy for the treatment of relapsed or refractory multiple myeloma","volume":"13","author":"Berenson","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170520220354_bib8","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/cncr.23855","article-title":"Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia","volume":"113","author":"Roboz","year":"2008","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20170520220354_bib9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.0007-1048.2001.03298.x","article-title":"Dual effects of arsenic trioxide (As 2 O 3 ) on non-acute promyelocytic leukaemia myeloid cell lines: induction of apoptosis and inhibition of proliferation","volume":"116","author":"Rojewski","year":"2002","journal-title":"Br. J. Haematol."},{"key":"key\n\t\t\t\t20170520220354_bib10","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nature07016","article-title":"PML targeting eradicates quiescent leukaemia-initiating cells","volume":"453","author":"Ito","year":"2008","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170520220354_bib11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1126\/science.1183424","article-title":"Arsenic trioxide controls the fate of the PML-RARa oncoprotein by directly binding PML","volume":"328","author":"Zhang","year":"2010","journal-title":"Science"},{"key":"key\n\t\t\t\t20170520220354_bib12","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1074\/jbc.M007204200","article-title":"Inhibition of NF-kappa B activation by arsenite through reaction with a critical cysteine in the activation loop of Ikappa B kinase","volume":"275","author":"Kapahi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170520220354_bib13","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/sj.leu.2404140","article-title":"Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-C","volume":"20","author":"Pelicano","year":"2006","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20170520220354_bib14","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1182\/blood-2004-07-2802","article-title":"Pharmacologic inhibitors of PI3K\/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells","volume":"105","author":"Ramos","year":"2005","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170520220354_bib15","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1182\/blood.V99.9.3136","article-title":"Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report","volume":"99","author":"Lu","year":"2002","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170520220354_bib16","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1368-7646(02)00120-6","article-title":"Activation of the PI3K\/Akt pathway and chemotherapeutic resistance","volume":"5","author":"West","year":"2002","journal-title":"Drug Resist. Updat."},{"key":"key\n\t\t\t\t20170520220354_bib17","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1038\/sj.onc.1207115","article-title":"PI3K\/Akt and apoptosis: size matters","volume":"22","author":"Franke","year":"2003","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170520220354_bib18","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1182\/blood.V98.8.2301","article-title":"Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells","volume":"98","author":"Guzman","year":"2001","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170520220354_bib19","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood-2002-11-3429","article-title":"Survival of acute myeloid leukemia cells requires PI3 kinase activation","volume":"102","author":"Xu","year":"2003","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170520220354_bib20","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nature04703","article-title":"Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells","volume":"441","author":"Yilmaz","year":"2006","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170520220354_bib21","doi-asserted-by":"crossref","first-page":"16220","DOI":"10.1073\/pnas.252462599","article-title":"Preferential induction of apoptosis for primary human leukemic stem cells","volume":"99","author":"Guzman","year":"2002","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"key\n\t\t\t\t20170520220354_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1432-1033.1981.tb06218.x","article-title":"Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors","volume":"115","author":"Chou","year":"1981","journal-title":"Eur. J. Biochem."},{"key":"key\n\t\t\t\t20170520220354_bib23","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nm1483","article-title":"Targeting of CD44 eradicates human acute myeloid leukemic stem cells","volume":"12","author":"Jin","year":"2006","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170520220354_bib24","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.cell.2008.10.048","article-title":"Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair","volume":"135","author":"Wilson","year":"2008","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170520220354_bib25","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/carcin\/bgp249","article-title":"A novel oncolytic adenovirus selectively silences the expression of tumor-associated STAT3 and exhibits potent antitumoral activity","volume":"30","author":"Han","year":"2009","journal-title":"Carcinogenesis"},{"key":"key\n\t\t\t\t20170520220354_bib26","first-page":"851","article-title":"Arsenic trioxide inhibits growth of human multiple myeloma cells in the bone marrow microenvironment","volume":"1","author":"Hayashi","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"key\n\t\t\t\t20170520220354_bib27","first-page":"341","article-title":"A dual PI3 kinase\/mTOR inhibitor reveals emergent efficacy in glioma. Cancer","volume":"9","author":"Fan","year":"2006","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170520220354_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/MOH.0b013e3283257aee","article-title":"Differentiation therapy of acute myeloid leukemia: past, present and future","volume":"16","author":"Petrie","year":"2009","journal-title":"Curr. Opin. Hematol."},{"key":"key\n\t\t\t\t20170520220354_bib29","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJMra0707704","article-title":"EGFR antagonists in cancer treatment","volume":"358","author":"Ciardiello","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170520220354_bib30","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1038\/onc.2008.239","article-title":"PTEN signaling in brain: neuropathology and tumorigenesis","volume":"27","author":"Endersby","year":"2008","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170520220354_bib31","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrd2350","article-title":"'Back to the future' for Chinese herbal medicines","volume":"6","author":"Qiu","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"key\n\t\t\t\t20170520220354_bib32","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1158\/0008-5472.CAN-05-3153","article-title":"Cancer stem cells: an old idea\u2013a paradigm shift","volume":"66","author":"Wicha","year":"2006","journal-title":"Cancer Res."}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/32\/10\/1550\/17289858\/bgr176.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T09:22:16Z","timestamp":1503566536000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article-lookup\/doi\/10.1093\/carcin\/bgr176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,29]]},"references-count":32,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2011,7,29]]},"published-print":{"date-parts":[[2011,10]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgr176","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,29]]}}}